Patent · US Active

Agonist antibodies that bind human CD137 and uses thereof

US10716851B2 · kind B2 · utility

0Cited by

21References

5Claims

0Family size

Assignee

Compass Therapeutics LLC · US

Inventors

Piotr Bobrowicz · Lebanon, US
Paul Fredrick Widboom · Lebanon, US
Michael March Schmidt · Cambridge, US
Jason M. Lajoie · Cambridge, US
Robert V. Tighe, III · North Reading, US
Cheuk Lun Leung · Cambridge, US
Ugur Eskiocak · Cambridge, US

Key dates

Filing date	Sep 6, 2018
Grant date	Jul 21, 2020
Priority date	—
Expiry date	Sep 6, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/75
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to, inter alia, compounds (e.g., antibodies, or antigen-binding fragments thereof) that bind to an epitope of CD137 and agonize CD137, and to use of the compounds in methods for treating, or ameliorating one or more symptoms of, cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.